B
Bull
Bull · 25%SMLR
$37.14
シナリオ価格
$20.330
-0.990 (-4.87%)終値時点
Loading chart…
- High
- 21.390
- Open
- 21.370
- VWAP
- 20.66
- Vol
- 1.62M
- Mkt Cap
- 245.54M
- Low
- 20.270
- Amount
- 33.56M
- EV/EBITDA, TTM
- -13.59
Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
Analyst Ratings (1)
+150.86% upside
Buy
1 Buy
0 Hold
0 Sell
Current: 20.33
安値
51.00
平均
51.00
高値
51.00
Maxim
Buy
$80
2025-09-19
Maxim
2025-09-19
目標株価
$80
Buy
Maxim
Buy
$95
2025-07-09
Maxim
2025-07-09
目標株価
$95
Buy
Lake Street
Strong Buy
$71
2025-01-24
Lake Street
2025-01-24
目標株価
$71
Strong Buy
B. Riley Securities
Hold
$45
2022-11-02
B. Riley Securities
2022-11-02
目標株価
$45
Hold
B. Riley Securities
Strong Buy
$60
2022-05-03
B. Riley Securities
2022-05-03
目標株価
$60
Strong Buy
バリュエーション指標
The current forward P/E ratio for Semler Scientific Inc (SMLR) is -14.57, compared to its 5-year average forward P/E of 18.01.
Alphio AI Price Scenarios for SMLR
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding SMLR
イベントタイムライン
ニュース
8.501-16GlobenewswireStrive, Inc. Completes Semler Scientific Acquisition, Holds 12,797.9 Bitcoin
2.012-30Barron'sCrypto Treasury Stocks, Including Strategy, Encounter a Risky Downward Trend: Ways to Overcome It.
4.512-30Barron'sMSTR Stock: Strategies and Other Crypto Reserves Encounter a Risky Downward Trend.
8.512-12PRnewswireSemler Scientific to be Sold to Strive, Shareholders to Receive 21.05 Shares Each
8.512-09GlobenewswireWohl & Fruchter Investigates Semler-Strive Merger Fairness Amid Fixed Exchange Ratio Concerns
SMLR FAQ — answered by Alphio AI
Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
1 analysts cover SMLR: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 51.00.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。